Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 176.40
0.00 (0.00%)
Aug 10, 2026, 4:59 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 13.47 billion as of August 10, 2026. Its market cap has decreased by -27.18% in one year.
Market Cap
13.47B
Enterprise Value
11.32B
Revenue
5.96B
Ranking
n/a
PE Ratio
11.89
Stock Price
176.40
ChartMarket Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 13.47B, an increase of 31,432.97%. That is a compound annual growth rate of 23.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 13.47B | -9.84% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Genmab | 119.34B |
| Coloplast | 98.51B |
| Demant | 59.52B |
| H. Lundbeck | 40.02B |
| Zealand Pharma | 23.25B |
| Ambu A/S | 19.37B |
| GN Store Nord | 14.39B |